Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Heart Lung Transplant. 2016 Aug 20;36(3):340–354. doi: 10.1016/j.healun.2016.08.011

Figure 4. RhoA deletion does not impair bone marrow and blood monocytes.

Figure 4

(A–B) The BRDU proliferation assay of bone marrow of CD11b+ monocytes shows no statistically significant difference in proliferation between wild type and RhoA-deleted mice. Flow cytometry analysis of CCR2+/CD115+ /CD11b+cells (monocytes) in bone marrow (C, D) and CD11b+/CD115+/CD45+ monocytes in blood (E, F) shows no significant difference between wild type and RhoA-deleted mice. Y-axis in graph D represents percentage of CD115+ cells among all bone marrow cells and in graph F the percentage of CD115+ monocytes among all blood cells. 3 mice from each experimental group were used.